Archive for the ‘Gene Therapy Research’ Category

Current ratings for: Genetic brain development 'peaks before birth and in adolescence'

Public / Patient:

0 (0 votes)

Health Professionals:

0 (0 votes)

Genetic expression behind the development of our brains is most active before birth, in the early months of pregnancy, and during our teenage years, scientists have found.

There is a quieter intervening "movement" in the three-part "symphony" of human brain development, but one that is more sensitive to environmental factors, say the researchers publishing in the journal Neuron.

The initial surge of brain-developing genetic expression takes place during the first two-thirds of our gestation in the uterus, says the team led from the Yale School of Medicine in New Haven, CT.

The middle intermission then lasts from the final trimester of pregnancy until adolescence, at which point the genetic activity surges again for the final phase of our brain's development.

These two most active spurts relevant to human brain power, found to sandwich the childhood years, involve the development of the cerebral neocortex:

More here:
Genetic brain development 'peaks before birth and in adolescence'

"Genetics", Gregor Mendel

By: MyCyberCollege

Read the original:
"Genetics", Gregor Mendel - Video

5 Genetic Discoveries in 2013
2013 was a big year in the world of gene research. We #39;re learning incredible things about why we are the way we are. Guest host Cristen Conger of Stuff Mom N...

By: DNews

Read the original post:
5 Genetic Discoveries in 2013 - Video

Current ratings for: Gene found that 'protects against neurodegenerative diseases'

Public / Patient:

4.3 (3 votes)

Health Professionals:

5 (1 vote)

Scientists from the University of Queensland in Australia say they have discovered that a gene called mec-17 has the ability to protect against adult-onset progressive nerve degeneration. This is according to a study published in the journal Cell Reports.

The research team, led by Dr. Brent Neumann of the Queensland Brain Institute (QBI) at the University of Queensland, say their discovery may one day lead to a cure for a number of neurodegenerative diseases, such as motor neuron disease, Parkinson's disease, Huntington's disease and Alzheimer's disease.

To reach their findings, the investigators analyzed a small roundworm called Caenorhabditis elegans. They note that the roundworm is a genetic model commonly used to better understand neurobiology at a basic level.

From this, they discovered that mec-17 - a gene found among many species - protects axons, also known as nerve fibers. These are parts of the nerve cells, or neurons, that are responsible for conducting impulses between the cells.

The gene protects the axon by sustaining its cytoskeletal structure, say the investigators. This is made of proteins that maintain a nerve cell's shape, support and movement.

Continued here:
Gene found that 'protects against neurodegenerative diseases'

Tent-op 2 - Canadian Connoisseur Genetics. Fireberry OG Kush, Bio Diesel
Here is going into week 5 ( day 33 of flower) and my new clones for next round at 3.5 weeks into veg from being 2 inches tall.

By: ChronicSimmons

Read the original:
Tent-op 2 - Canadian Connoisseur Genetics. Fireberry OG Kush, Bio Diesel - Video

George Church introduction at HMS Genetics
Harvard Medical School Genetics Leadership Summit 2013 Fall Meeting.

By: Reese Jones

See more here:
George Church introduction at HMS Genetics - Video

Minecraft FTB Horizons - Advanced Genetics - S3E14
I #39;m a geneticist! http://feed-the-beast.com/ Installation - https://www.youtube.com/watch?v=TjPKkgZI2H0 Minecraft: https://minecraft.net/ Minecraft.net forum...

By: Surg

Originally posted here:
Minecraft FTB Horizons - Advanced Genetics - S3E14 - Video

DEKALB Genetics Dealer Recruiting Informational Video
An informational video supplied to perspective DEKALB Genetic #39;s seed dealers.

By: DeKalb Area Agricultural Heritage Association (DAAHA)

Read more here:
DEKALB Genetics Dealer Recruiting Informational Video - Video

DNA Genetics / Big Buddha TrueCanna Genetics / Greenhouse Seeds Seminar PART 3 Cannabis Cup 2013
http://andrew.pyrah.net Thanks for watching! COMMENT and LIKE if you enjoyed the video and SUBSCRIBE to see my new videos as they are released. This video is...

By: Andrew Pyrah

Read the original:
DNA Genetics / Big Buddha TrueCanna Genetics / Greenhouse Seeds Seminar PART 3 Cannabis Cup 2013 - Video

Amid somewhat of a renaissance in drug development for orphan diseases, another gene therapy company announced funding today for a potential treatment for a rare neurodegenerative condition called Friedreichs ataxia (FRDA).

Agilis Biotherapeutics said its raised $8 million and will work with synthetic biology company Intrexon Corp. to develop gene therapies and genetically modified cell therapies for FRDA. Whereas current treatments focus on minimizing symptoms of the disease, the partners expect their drugs to be able to target the underlying disease mechanisms.

FRDA is caused by a genetic defect that results in limited production of frataxin, a protein thought to help assemble clusters of iron and sulfur molecules in cells that are necessary for the function of many other proteins. When cells are deficient of frataxin, they may not function properly, causing damage to the nervous system and problems with movement. Most people with the disease become wheelchair-bound within two decades of diagnosis, and many die early due to weakened heart muscles.

The goal for Agilis and Intrexon is to use Intrexons gene switch technology to develop drugs that will repair the defective gene and enable increased production of the frataxin protein. Under the options of the deal, Agilis and Intrexon could add another rare genetic disease to the collaboration.

Ahead of the pair in developing new treatments for the rare disease are ViroPharma, which is in Phase 1 development of a small molecule drug for FA, and Edison Phamaceuticals, which is conducting a Phase 2 study of its drug.

[Image credit: LendingMemo.com]

Read more from the original source:
Rare disease biotech picks up $8M, drug development partner for DNA-based therapies

Back to basicsCaveman workout is the choice for functional training.

Swim, bike and runtriathlon became even more popular in 2013.

It was the year stem cell therapy became a household name.

Although the science has been around for half a century in Europe, it was not until the Asian Institute of Longevity Medicine (AILM) opened its doors to Filipinos in 2009 that stem cell therapy took off in the country.

Today, AILMs German-based partner, Tissue and Cell Banking (Ticeba), headed by its founder and managing director Dr. Christoph Ganss, is one of the countrys most sought-after stem cell therapy consultants.

If you think that, because of its exceedingly high price tag, stem cell therapy would catch on only among the well-heeled, think again. Entrepreneurial Pinoys saw the potential moneymaker in the name, and soon peddlers began brandishing everything from stem cell water to stem cell fertility kits.

Another top hit of 2013 is juicing/detox. Now a multibillion-dollar industry in the United States, juicingwhile it has been practiced by many vegans and vegetarians in the Philippines since the early 2000sbecame big this year when the Australian documentary filmmaker and juicing advocate Joe Cross visited the country.

Today, there are three major competing organic juice brands on the market.

Organic produce

Vegan food the five-star way

Continue reading here:
Stem cells, juicing, Piloxing, triathlon, workout apps–health and wellness on overdrive

Myriad Genetics Inc. (MYGN), a provider of gene tests for breast cancer, fell to its lowest value in almost two years after the U.S. proposed cutting reimbursements for the diagnostic service by almost half.

Myriad dropped 16 percent to $20.26 at 10:21 a.m. New York time after declining to $20.02, its lowest intraday price since Jan. 5, 2012. The shares had lost 11 percent in the 12 months through Dec. 27.

The Centers for Medicare and Medicaid Services will hold a public comment period through Jan. 27 on the proposed lower rates, Myriad said in a filing today. The Salt Lake City-based company will have trouble getting high reimbursements for the tests from the U.S. and other payers, said Peter Lawson, an analyst with Mizuho Securities Co.

Negative pricing overhangs have increased beyond our comfort level, Lawson said in a note to clients today. He reduced his rating on the stock to hold from buy.

Medicare, the U.S. health-insurance program for the elderly and disabled, will pay $1,438 next year for sequencing of the BRCA1 and BRCA2 genes, which are associated with breast cancer, the company said in a filing today. That figure is down from a government determination in September to pay $2,795 for the test. Medicare makes up about 10 percent of Myriads BRCA testing sales, Lawson said.

Myriad held a U.S. monopoly over the BRCA tests until June, when the U.S. Supreme Court invalidated parts of its gene patents. Afterward, Quest Diagnostics Inc. (DGX), Ambry Genetics Corp. and another closely held company said they were entering the BRCA market.

Mutations in the BRCA1 and BRCA2 genes, the most common cause of hereditary breast and ovarian cancer, are present in about one in 400 women and indicate an elevated risk.

To contact the reporter on this story: Drew Armstrong in New York at darmstrong17@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

See original here:
Myriad Genetics Drops After U.S. Cuts Rate for Gene Test

Dec. 23, 2013 New findings suggest the oxytocin receptor, a gene known to influence mother-infant bonding and pair bonding in monogamous species, also plays a special role in the ability to remember faces. This research has important implications for disorders in which social information processing is disrupted, including autism spectrum disorder. In addition, the finding may lead to new strategies for improving social cognition in several psychiatric disorders.

A team of researchers from Yerkes National Primate Research Center at Emory University in Atlanta, the University College London in the United Kingdom and University of Tampere in Finland made the discovery, which will be published in an online Early Edition of Proceedings of the National Academy of Sciences.

According to author Larry Young, PhD, of Yerkes, the Department of Psychiatry in Emory's School of Medicine and Emory's Center for Translational Social Neuroscience (CTSN), this is the first study to demonstrate that variation in the oxytocin receptor gene influences face recognition skills. He and co-author David Skuse point out the implication that oxytocin plays an important role in promoting our ability to recognize one another, yet about one-third of the population possesses only the genetic variant that negatively impacts that ability. They say this finding may help explain why a few people remember almost everyone they have met while others have difficulty recognizing members of their own family.

Skuse is with the Institute of Child Health, University College London, and the Great Ormond Street Hospital for Children, NHS Foundation Trust, London.

Young, Skuse and their research team studied 198 families with a single autistic child because these families were known to show a wide range of variability in facial recognition skills; two-thirds of the families were from the United Kingdom, and the remainder from Finland.

The Emory researchers previously found the oxytocin receptor is essential for olfactory-based social recognition in rodents, like mice and voles, and wondered whether the same gene could also be involved in human face recognition. They examined the influence of subtle differences in oxytocin receptor gene structure on face memory competence in the parents, non-autistic siblings and autistic child, and discovered a single change in the DNA of the oxytocin receptor had a big impact on face memory skills in the families. According to Young, this finding implies that oxytocin likely plays an important role more generally in social information processing, which is disrupted in disorders such as autism.

Additionally, this study is remarkable for its evolutionary aspect. Rodents use odors for social recognition while humans use visual facial cues. This suggests an ancient conservation in genetic and neural architectures involved in social information processing that transcends the sensory modalities used from mouse to man.

Skuse credits Young's previous research that found mice with a mutated oxytocin receptor failed to recognize mice they previously encountered. "This led us to pursue more information about facial recognition and the implications for disorders in which social information processing is disrupted." Young adds the team will continue working together to pursue strategies for improving social cognition in psychiatric disorders based on the current findings.

The rest is here:
Gene that influences the ability to remember faces identified

Let #39;s Play The Sims 3 - Perfect Genetics Challenge - Episode 34
My Sims 3 Page: http://mypage.thesims3.com/mypage/Llandros2012 My Blog: http://Llandros09.blogspot.com My Facebook: https://www.facebook.com/Llandros09?ref=t...

By: Llandros09

Follow this link:
Let's Play The Sims 3 - Perfect Genetics Challenge - Episode 34 - Video

Seinfeld - Season 05, Episode 01 - About plants genetics 🙂

By: DAHUJI1980

More:
Seinfeld - Season 05, Episode 01 - About plants genetics 🙂 - Video

DNA Genetics / Big Buddha / True Canna Genetics / Greenhouse Seeds Seminar PART 2 Cannabis Cup 2013
http://andrew.pyrah.net Thanks for watching! COMMENT and LIKE if you enjoyed the video and SUBSCRIBE to see my new videos as they are released. This video is...

By: Andrew Pyrah

View post:
DNA Genetics / Big Buddha / True Canna Genetics / Greenhouse Seeds Seminar PART 2 Cannabis Cup 2013 - Video

EDMONTON-In the flurry of news reports that followed the revelation that Angelina Jolie underwent a double mastectomy, many left out a crucial detail: the gene mutation that led to the actress decision to undergo surgery is relatively rare.

Thats the finding of a University of Alberta researcher currently working on a book about how celebrities impact peoples health and other lifestyle decisions.

Sixty-eight per cent of articles did not discuss the rarity of the gene, which is very important since her situation is actually tremendously rare, said Timothy Caulfield, Canada Research Chair in Health Law and Policy.

The good news is they did a fairly good job when they talked about the science and talked about the risks associated with preventive mastectomy.

Jolie revealed her decision in a piece published in the May 14, 2013 edition of the New York Times. She wrote that her mother had died of breast cancer at the age of 56 and she had inherited a mutation in the BRCA 1 gene. Doctors had estimated she had an 87-per-cent risk of breast cancer. She underwent a preventive double mastectomy, which reduced her breast cancer risk to less than five per cent.

Jolie herself wrote that, Only a fraction of breast cancers result from an inherited gene mutation.

Alberta researchers say 95 per cent of women who have breast cancer never test positive for the gene mutation.

In their research, Caulfield and two others analyzed 103 news and opinion pieces published in major American, British and Canadian newspapers, including the New York Times, the Globe and Mail and the Guardian.

The study did not include the Edmonton Journal or Calgary Herald, which ran locally written articles about Jolies mastectomy that mentioned the rarity of her condition.

The researchers combed through the articles, looking for various themes such as the cost and drawbacks of preventive mastectomies or mentions of alternatives to surgery for breast cancer prevention. From there, more analysis was done to identify the tone of the articles.

Read the original:
Rarity of Angelina Jolie’s gene mutation condition under-reported, says researcher

Lets Play The Sims 3 Perfect Genetics Ch Baby #1 arrives

By: Sims Family Challenges

See original here:
Lets Play The Sims 3 Perfect Genetics Ch Baby #1 arrives - Video

In a book packed with fascinating anecdotes, its hard to pick out highlights from David EpsteinsThe Sports Gene.

However, pushed to do exactly that, this writer cannot overlook the story of Superbaby. Sometime around the year 2000, a baby was born in a Berlin hospital, but not any normal baby. Doctors noticed the childs bulging biceps, his chiseled calves and glutes that [y]ou could bounce nickel off.

By the tender age of four Superbaby had no trouble holding 6.6-pound [3kg] dumbbells suspended horizontally at arms length. The boy looked normal with his clothes on but underneath, his muscles were roughly double the size of similarly aged male children.

Epstein continues to explain how a lack of the protein myostatin part of the GDF-8 gene can result in this remarkable genetic abnormality, before delving into similar examples in mice and whippets. The chapter concludes by suggesting some of the lessons we can take from the science, a trait throughout the book.

Epstein is a Columbia University graduate who has become universally-regarded for his investigative reporting for Sports Illustrated in the US. He co-authored the revelation that Alex Rodriguez, the baseball star, had tested positive for steroids in 2003, the same year he was named the American Leagues Most Valuable Player award.

The byline ofThe Sports Gene reads, Inside the Science of Extraordinary Athletic Performance. Its very self-explanatory, with Epstein drawing together mountains of scientific research into sporting achievement to reveal the physical, genetic traits that certain athletes possess.

The joy of this book is its balance; Epstein continually acknowledges that practice can be vital in producing world-class performers, even if it is on occasion unnecessary. Many commentators see The Sports Gene as a response to the so-called 10,000-hour rule, which burst into the mainstream after Malcolm Gladwell provided an incomplete overview of it in his 2008 book Outliers: The Story of Success.

Gladwell is seen as one of the main drivers of a widely accepted, but highly debatable, notion that talent doesnt matter, 10,000 hours of deliberate practice will make anyone an expert in anything they desire to do. While there are certainly positives in people believing that, it doesnt tell the whole story.

Thats where Epsteins work comes in, providing us with thrillingly readable scientific fact about what physically makes the best sporting performers. However, he balances that utterly with the repeated statement that training is important too, although not necessarily 10,000 hours of it.

Epsteins own fascination with the subject matter is infectious, making The Sports Gene such a pleasure to read. The former 800 metres runner believes that the study of genetics can help us to improve selection of athletes for particular sports. A persons body shape may mean that they can never be sprinter, but those same physical elements might mean they have potential in swimming, for example.

Read more here:
‘The Sports Gene’ should be top of your post-Christmas book list

A genetic risk factor for type 2 diabetes commonly found in the DNA of Mexican and Latin American people was likely inherited from Neanderthals when they interbred with humans some 50,000 years ago, according to an exhaustive new analysis.

Scientists at the Broad Institute, a Cambridge genomic research center, worked with colleagues to compare more than 9 million spots in the genomes of 8,000 Latin Americans and found a version of a gene that increased a persons risk for the disease by about 20 percent. The research, published Wednesday in the journal Nature, was supported by Mexican billionaire Carlos Slim Hel, who visited the Broad Institute this fall to announce a $74 million gift for continued genetics research in Latin American populations.

At the time, Eric Lander, director of the Broad Institute, pointed to this resultwhich was not yet publishedas an example of the importance of studying the genomes of diverse populations, because genetic risk factors for diseases may not be the same.

It had been missed in all the studies of European patients, and yet it turns out to be one of the most powerful genes that is known to affect diabetes, Lander said then. The abstract idea that studying Mexican populations would lead to discoveries that are being missed turns out to be right.

Mexican and Latin American people have about twice the rate of diabetes as non-Hispanic white people in the U.S., leading researchers to wonder whether there were different genetic risk factors. By comparing the same 9.2 million spots in the DNA of Mexican and Latin American people with and without diabetes, they were able to identify a number of versions of genes more common in people with the disease. Many of those had already been identified in previous genetic studies of the disease, which have typically been done in European populations. But they were especially intrigued by one new gene strongly associated with the disease, with changes to five letters in a gene called SLC16A11.

That version of the gene was nearly absent from African populations and rarely seen in Europeans. It was found in about 10 percent of Asians, and in about half of Native Americans, raising the suggestion that it entered the human gene pool after humans left Africa.

We were intrigued, and it eventually dawned on us that archaic interactioncrossbreeding with Neanderthalsmight be the source of this, said Amy Williams, a post-doctoral researcher at the Broad and Harvard Medical School. Williams and colleagues got access to a new Neanderthal genome sequence and found it there, suggesting that the version of the gene entered the human population when the two species interbred.

That doesnt suggest that Latin Americans have any more or less Neanderthal DNA than the rest of us. Studies have found that people outside Africa have roughly the same small amount2 percent of Neanderthal. Williams said analyses suggest that the gene was not adaptive or subject to natural selection, but rose in frequency due to chancerandom genetic drift.

The task ahead for the team now is to better understand the role the gene may play in causing the disease. Initial studies revealed that it is active in fat metabolism in the liver, and researchers at the Broad hope to understand the biology to help inform the hunt for therapies.

Read more here:
Diabetes risk factor common in Latin Americans likely inherited from Neanderthals

By Traci Pedersen Associate News Editor Reviewed by John M. Grohol, Psy.D. on December 28, 2013

A genetic variant known to make some people hypersensitive to stress is also linked to a 38 percent increased risk of heart attack or death in patients with heart disease, according to researchers at Duke Medicine.

Weve heard a lot about personalized medicine in cancer, but in cardiovascular disease we are not nearly as far along in finding the genetic variants that identify people at higher risk, said senior author Redford B. Williams Jr., M.D., director of the Behavioral Medicine Research Center at Duke University School of Medicine.

Here we have a paradigm for the move toward personalized medicine in cardiovascular disease.

The researchers built on previous work at Duke and elsewhere that identified a variation in a DNA sequence, known as a single nucleotide polymorphism (SNP), where one letter in the genetic code is swapped for another to change the genes function. The team focused on a particular SNP that occurs on the gene that makes a serotonin receptor and causes a hyperactive reaction to stress.

In a previous study, researchers found that men with this genetic variant had twice as much cortisol in their blood when exposed to stress, compared to men without the variant.The stress hormonecortisol is produced in the adrenal gland to support the bodys biological response when reacting to a situation that causes negative emotions.

It is known that cortisol has effects on the bodys metabolism, on inflammation and various other biological functions, that could play a role in increasing the risk of cardiovascular disease, said lead author Beverly H. Brummett, Ph.D., associate professor of psychiatry and behavioral sciences at Duke.

It has been shown that high cortisol levels are predictive of increased heart disease risk. So we wanted to examine this more closely.

The exciting part to me this is that this genetic trait occurs in a significant proportion of people with heart disease, Brummett said. If we can replicate this and build on it, we may be able to find ways to reduce the cortisol reaction to stress either through behavior modification or drug therapies and reduce deaths from heart attack.

Researchers used a database to run a genetic analysis of more than 6,100 white participants, two-thirds of whom were men, and one-third women. About 13 percent of this group had the genetic variation for the overactive stress response.

Read more:
Stress Reaction Gene Tied to Heart Attacks

silent hill - savage genetics remix

By: timez lawliet

Continue reading here:
silent hill - savage genetics remix - Video

MrReaplos Dienstag - Advanced Genetics Mod Review [1.6.4]
Das Spiel : Minecraft Webseite : http://www.minecraft.net Texturepack : ...

By: LPTeamDE

See more here:
MrReaplos Dienstag - Advanced Genetics Mod Review [1.6.4] - Video

Advanced Genetics Mod Review- Part 1
How amazing! It #39;s wonderful what the scientists in the lab can whip up with now adays, allow you to extract DNA from and animal, and inject it into yourself?...

By: LordTeutonic

Read more:
Advanced Genetics Mod Review- Part 1 - Video

Cosmic Log

Alan Boyle, Science Editor NBC News

19 hours ago

Genetics isn't just for the living, as the past year's scientific revelations have demonstrated. Whether it's identifying King Richard III's long-lost bones or tracing humanity's tangled family tree, DNA analysis is shedding new light on mysteries that have lain buried for ages.

New technologies addressed longstanding questions in other contexts during 2013. Here are five of the year's leading themes, plus five bonus scientific highlights and links to five additional end-of-the-year roundups.

DNA unravels history's mysteries: In February, genetics clinched the case for King Richard III's remains, which British archaeologists recovered from beneath a parking lot in Leicester. Richard III was famous as one of Shakespeare's best-known villains, but the chroniclers lost track of his bones soon after his defeat and death on Bosworth Field in 1485. Analyses of his rediscovered remains proved the truth of what Shakespeare said with regard to a different English king: "Uneasy lies the head that wears the crown." Forensic analysis found that the poor royal suffered from scoliosis, roundworms and other ailments. And Richard's troubles aren't over yet: Interested parties in Leicester and York are still fighting over who has rightful custody of his bones. On other fronts, genetics is being applied to the mysteries surrounding the fates of French King Henry IVand England's Alfred the Great.

DNA points to complexity in human origins: This month, scientists announced that they deciphered 400,000-year-old DNA extracted from bones found in a Spanish cave. That technical achievement set a record, but it also turned up something unexpected: genetic linkages to a mysterious population of human ancestors in Siberia, known as Denisovans. Other studies have pointed to interbreeding among Neanderthals, Denisovans and ancient representatives of our own species, Homo sapiens. DNA signatures even hint at humanlike populations yet to be identified. Such findings support the view that our family tree isn't organized into clear-cut roots and branches, but instead consists of bushy, messy tangles.

Lost cities uncovered: Laser scanning, aerial imaging and other high-tech tools have revealed a previously uncharted ancient settlement in Cambodia that predated Angkor Wat, ruins in Peru that predated the Inca culture, andstructures in Honduras that might have inspired conquistadors' tales of a treasure-laden city. The methods available to archaeologists today would make Indiana Jones green with envy. "I go out and do archaeology with a ray gun," the University of Sheffield's Ellery Frahm told LiveScience. "It doesn't get more sci-fi than that."

Discoveries from Antarctica's depths: Antarctica may seem like a frozen wasteland, but it can be a wonderland for the right kinds of research. In January, Russian scientists brought up fresh samples of ice from Lake Vostok, a body of water that lies hidden beneath a 2-mile-deep layer of ice. In July, they reported that the ice contained samples from a wide assortment of life forms, even though the lake has seemingly been cut off from the rest of the world for millions of years. Meanwhile, detectors buried in Antarctica's ice were used to make a completely different kind of discovery: the first signs of high-energy neutrinos from beyond our solar system. Those detectors, part of the international IceCube experiment, could point the way to an entirely new kind of astronomy, based on neutrinos instead of old-fashioned photons.

Clarity about climate change: Atmospheric readings of carbon dioxide exceeded 400 parts per million this year, raising fresh warnings about the greenhouse-gas effect. Climate-change skeptics tried to make the case that global warming has stalled, based on temperature readings from recent years, but researchers came up with a different explanation: Right now, much of the planet's excess heat is being soaked up by the ocean rather than the atmosphere. Such findings were factored into the Intergovernmental Panel on Climate Change's latest report, which suggested establishing a cumulative cap on carbon emissions.

See the article here:
Year in science: Old bones yield new revelations about kings and genes